A free 30-minute lunchtime session on the six principles of LabOps Safety by Design and how the best biotechs & life sciences organisations are embedding HSE compliance into procurement instead of bolting it on top.
Hosted by MyAmici experts, joined by Chartered HSE consultant Jenny Morgenstern (Regulus Safety).
What if lab safety compliance took care of itself? Instead of chasing documentation or relying on scientists to remember the right steps, you could focus on enabling scientific progress, confident that every procurement decision is compliant, evidenced, and audit-ready.
That’s the angle we’re taking in our next session: LabOps Safety by Design, making lab safety the default, not the burden.
This webinar walks through how it’s done. Six principles. Real case studies. Live Q&A. Just 30 minutes of practical content you can apply the same week. Register here.
The six principles of LabOps Safety by Design
We’ll cover all six in plain terms, with examples drawn from real biotech operations:
01 · Put safety where decisions happen. Why hazard visibility at the point of purchase outperforms PPE and reactive measures.
02 · Make compliance the easiest path. When the safest option is also the fastest, people follow it by default.
03 · Two interception points, not one. Why catching risks at requisition AND goods-in absorbs the failures of each individual check.
04 · Scientists assess. Systems prompt. The clean division between scientific judgment (which can’t be automated) and recurring compliance verification (which shouldn’t depend on memory).
05 · Audit trails as a by-product. How to build a continuous, retrievable audit trail without the audit-week scramble.
06 · Safety culture starts at the top. Why the first five principles can all be in place and still fail without visible leadership commitment.
We’re delighted to be joined by Jenny Morgenstern, BSc (Hons), PGDip, CMIOSH, MISTR a Chartered Member of the Institution of Occupational Safety and Health with over 12 years of HSE experience.
Jenny specializes in chemical safety and ergonomics, with a strong background in biological safety (covering humans, animals and insects), cryogenics, and sustainability. She’ll bring an independent consultant’s perspective to the conversation including the practical realities of getting buy-in for change in scientific organizations.
This isn’t a generic safety culture talk. It’s specifically designed for: Heads of lab operations and facilities in biotechs scaling from 20 to 200 where informal oversight has stopped working but formal systems haven’t been built yet. HSE managers and compliance leaders who want to embed controls into daily workflows rather than enforce them after the fact. Lab managers and PIs dealing with the day-to-day friction of compliance the missing SDS, the chased-down approval, the audit-week scramble. Procurement leaders in life sciences who recognize that purchase decisions are where the highest-consequence risks enter the buildin. CEOs and CSOs of growing biotechs who understand the legal weight of UK corporate law and want to know what good looks like If you’ve ever found a hazardous chemical on a shelf with no record of who ordered it or worried that you might this session is for you.
The webinar is based on our deeper guide, LabOps Safety by Design: How smarter procurement decisions create safer labs, stronger compliance, and enable scientific progress, written by Alison Crowley and Caroline Briggs. You can download it here.
The eBook covers all six principles in detail, with full case studies, regulatory references (Human Tissue Act, ACDP, HMRC excise rules, DSEAR, UK corporate manslaughter law), and a Bradley Curve diagnostic to help you locate your organization on the safety culture maturity scale.
Dive into a curated mix of thought leadership, industry insight, and behind-the-scenes biotech lab wins.
